MAPT and supranuclear palsy, progressive, 1: Another study used an assay of cerebrospinal fluid (CSF) tau (59, 63), which reported 84.2% sensitivity and 66.7% specificity for separating 21 patients with PSP-RS and 12 patients with CBS using the p-tau/t-tau ratio.